{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:47:16Z","timestamp":1778564836748,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Cerebellum"],"published-print":{"date-parts":[[2005,9,5]]},"DOI":"10.1080\/14734220500222318","type":"journal-article","created":{"date-parts":[[2005,9,15]],"date-time":"2005-09-15T05:48:40Z","timestamp":1126763320000},"page":"211-215","source":"Crossref","is-referenced-by-count":34,"title":["Treatment of cerebellar ataxia with 5\u2010HT1A agonist"],"prefix":"10.1007","volume":"4","author":[{"given":"Asako","family":"Takei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenao","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","first-page":"587","volume":"37","author":"Waragai M.","year":"1997","unstructured":"Waragai, M. and Ogawara, K. and Takaya, Y. and Hayashi, M. (1997) Efficacy of TRH\u2010T for spinocerebellar degeneration \u2013 the relation between clinical features and effect of TRH therapy. <i>Rinsho Shinkeigaku<\/i>, 37, pp. 587 - 94. [In Japanese]","journal-title":"Rinsho Shinkeigaku"},{"key":"E00002","first-page":"4169","volume":"13","author":"Kanazawa I.","year":"1997","unstructured":"Kanazawa, I. and Satoyoshi, E. and Hirayama, K. (1997) Clinical evaluation of taltirelin hydrate (TA\u20100910) in patients with spinocerebellar degeneration \u2013A multi\u2010center double\u2010blind comparative study with placebo. <i>Rinsyo Iyaku<\/i>, 13, pp. 4169 - 24. [In Japanese]","journal-title":"Rinsyo Iyaku"},{"key":"E00003","first-page":"353","volume":"48","author":"Fukuchi I.","year":"1998","unstructured":"Fukuchi, I. and Asahi, T. and Kawashima, K. and Kawashima, Y. and Yamamura, M. and Matsuoka, Y. and Kinoshita, K. (1998) Effects of Taltirelin hydrate (TA\u20100910), a novel thyrotropin\u2010releasing hormone analog, on in vivo dopamine release and turnover in rat brain. <i>Arzneimittelforschung<\/i>, 48, pp. 353 - 9.","journal-title":"Arzneimittelforschung"},{"key":"E00004","first-page":"6","volume":"5","author":"Trouillas P.","year":"1990","unstructured":"Trouillas, P. (1990) L\u20105\u2010Hydroxytryptophan treatment in cerebellar ataxia: Clinical and etiological correlations. <i>Mov Disord<\/i>, 5((Suppl.\u20051)), pp. 6.","journal-title":"Mov Disord"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archneur.1988.00520350055016","volume":"45","author":"Trouillas P.","year":"1988","unstructured":"Trouillas, P. and Brudon, F. and Adeleine, P. (1988) Improvement of cerebellar ataxia with levorotatory form of 5\u2010hydroxytryptophan. A double\u2010blind study with quantified data processing. <i>Arch Neurol<\/i>, 45, pp. 1217 - 22.","journal-title":"Arch Neurol"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/archneur.1995.00540340074015","volume":"52","author":"Lou J. S.","year":"1995","unstructured":"Lou, J. S. and Goldfarb, L. and McShane, L. and Gatev, P. and Hallett, M. (1995) Use of buspirone for treatment of cerebellar ataxia. An open\u2010label study. <i>Arch Neurol<\/i>, 52, pp. 982 - 8.","journal-title":"Arch Neurol"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archneur.1997.00550180059013","volume":"54","author":"Trouillas P.","year":"1997","unstructured":"Trouillas, P. and Xie, J. and Adeleine, P. and (1997) Buspirone, a 5\u2010hydroxytryptamine1A agonist, is active in cerebellar ataxia. Results of a double\u2010blind drug placebo study in patients with cerebellar cortical atrophy. <i>Arch Neurol<\/i>, 54, pp. 749 - 52.","journal-title":"Arch Neurol"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0079-6123(08)63389-0","volume":"114","author":"Trouillas P.","year":"1997","unstructured":"Trouillas, P. and Xie, J. and Adeleine, P. (1997) Buspirone, a serotonergic 5\u2010HT1A agonist, is active in cerebellar ataxia. A new fact in favor of the serotonergic theory of ataxia. <i>Prog Brain Res<\/i>, 114, pp. 589 - 99.","journal-title":"Prog Brain Res"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/mds.870120426","volume":"12","author":"Friedman J. H.","year":"1997","unstructured":"Friedman, J. H. (1997) Machado\u2010Joseph disease\/spinocerebellar ataxia 3 responsive to buspirone. <i>Mov Disord<\/i>, 12, pp. 613 - 14.","journal-title":"Mov Disord"},{"key":"E00010","first-page":"5","volume":"21","author":"Saito Y.","year":"1998","unstructured":"Saito, Y. and Miwa, S. and Yamana, T. and Hasegawa, Y. and Takagi, S. (1998) Clinical therapeutical trial of oral tandospirone for cerebellar ataxia. <i>Nagoya Shiritu Byouin Kiyou<\/i>, 21, pp. 5 - 8. [In Japanese]","journal-title":"Nagoya Shiritu Byouin Kiyou"},{"key":"E00011","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1440-1819.2002.00952.x","volume":"56","author":"Takei A.","year":"2002","unstructured":"Takei, A. and Honma, S. and Kawashima, A. (2002) Beneficial effects of tandospirone on ataxia of a patient with Machado\u2010Joseph disease. <i>Psychiatry Clin Neurosci<\/i>, 56, pp. 181 - 5.","journal-title":"Psychiatry Clin Neurosci"},{"key":"E00012","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1440-1819.2003.01176.x","volume":"57","author":"Takei A.","year":"2003","unstructured":"Takei, A. and Fukazawa, T. and Hamada, T. and Yabe, I. and Tashiro, K. (2003) \u2018Drug holiday\u2019 effects of tandospirone in a patient with Machado\u2010Joseph disease. <i>Psychiatry Clin Neurosci<\/i>, 57, pp. 607 - 8.","journal-title":"Psychiatry Clin Neurosci"},{"key":"E00013","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00002826-200401000-00005","volume":"27","author":"Takei A.","year":"2004","unstructured":"Takei, A. and Fukazawa, T. and Hamada, T. and Sohma, H. and Yabe, I. and Sasaki, H. and Tashiro, K. (2004) Effects of tandospirone on \u20185\u2010HT1A receptor\u2010associated symptoms\u2019 in patients with Machado\u2010Joseph disease. An open\u2010label study. <i>Clin Neuropharmacol<\/i>, 27, pp. 9 - 13.","journal-title":"Clin Neuropharmacol"},{"key":"E00014","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0165-6147(87)90231-8","volume":"8","author":"Traber J.","year":"1987","unstructured":"Traber, J. and Glaser, T. (1987) 5\u2010HT1A\u2010related anxiolytics. <i>Trends Pharmacol Sci<\/i>, 8, pp. 432 - 7.","journal-title":"Trends Pharmacol Sci"},{"key":"E00015","doi-asserted-by":"crossref","first-page":"10734","DOI":"10.1073\/pnas.95.18.10734","volume":"95","author":"Parks C. L.","year":"1998","unstructured":"Parks, C. L. and Robinson, P. S. and Sibille, E. and Shenk, T. and Toth, M. (1998) Increased anxiety of mice lacking the serotonin1A receptor. <i>Proc Natl Acad Sci USA<\/i>, 95, pp. 10734 - 9.","journal-title":"Proc Natl Acad Sci USA"},{"key":"E00016","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0006-8993(97)00758-0","volume":"770","author":"Bjorvatn B.","year":"1997","unstructured":"Bjorvatn, B. and Fagerland, S. and Eid, T. and Ursin, R. (1997) Sleep\/waking effects of a selective 5\u2010HT1A receptor agonist given systemically as well as perfused in the dorsal raphe nucleus in rats. <i>Brain Res<\/i>, 770, pp. 81 - 8.","journal-title":"Brain Res"},{"key":"E00017","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0006-8993(01)02101-1","volume":"897","author":"S\u00f8rensen E.","year":"2001","unstructured":"S\u00f8rensen, E. and Gr\u00f8nli, J. and Bjorvatn, B. and Bj\u00f8rkum, A. and Ursin, R. (2001) Sleep and waking following microdialysis perfusion of the selective 5\u2010HT1A receptor antagonist p\u2010MPPI into the dorsal raphe nucleus in the freely moving rat. <i>Brain Res<\/i>, 897, pp. 122 - 30.","journal-title":"Brain Res"},{"key":"E00018","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/BF02249416","volume":"125","author":"Vickers S. P.","year":"1996","unstructured":"Vickers, S. P. and Clifton, P. G. and Dourish, C. T. (1996) Behavioural evidence that d\u2010fenfluramine\u2010induced anorexia in the rat is not mediated by the 5\u2010HT1A receptor subtype. <i>Psychopharmacology<\/i>, 125, pp. 168 - 75.","journal-title":"Psychopharmacology"},{"key":"E00019","first-page":"pp 253","author":"GlennonR. A.","year":"1988","unstructured":"Glennon, R. A. and Lucki, I.(1988) Behavioural models of serotonin receptor activation.. In <i>The serotonin receptors.<\/i>. ( pp. pp 253 - 93 ). Clifton NJ: Humana Press."},{"key":"E00020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0149-7634(05)80055-7","volume":"16","author":"Lucki I.","year":"1992","unstructured":"Lucki, I. (1992) 5\u2010HT1 receptors and behaviour. <i>Neurosci Biobehav Rev<\/i>, 16, pp. 83 - 93.","journal-title":"Neurosci Biobehav Rev"},{"key":"E00021","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0304-3959(92)90042-A","volume":"50","author":"Giordano J.","year":"1992","unstructured":"Giordano, J. and Rogers, L. (1992) Putative mechanisms of buspirone\u2010induced antinociception in the rat. <i>Pain<\/i>, 50, pp. 365 - 72.","journal-title":"Pain"},{"key":"E00022","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-510X(96)00231-6","volume":"145","author":"Trouillas P.","year":"1997","unstructured":"Trouillas, P. and Takayanagi, T. and Hallett, M. (1997) International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. The ataxia neuropharmacology committee of the world federation of neurology. <i>J Neurol Sci<\/i>, 145, pp. 205 - 11.","journal-title":"J Neurol Sci"},{"key":"E00023","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archpsyc.1965.01720310065008","volume":"12","author":"Zung W. W. K.","year":"1963","unstructured":"Zung, W. W. K. (1963) A self\u2010rating depression scale. <i>Arch Gen Psychiat<\/i>, 12, pp. 63 - 70.","journal-title":"Arch Gen Psychiat"},{"key":"E00024","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0028-3908(93)90052-5","volume":"32","author":"Wieland S.","year":"1993","unstructured":"Wieland, S. and Fischette, C. T. and Lucki, I. (1993) Effect of chronic treatments with tandospirone and imipramine on serotonin\u2010mediated behavioral responses and monoamine receptors. <i>Neuropharmacology<\/i>, 32, pp. 561 - 573.","journal-title":"Neuropharmacology"},{"key":"E00025","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0014-2999(95)00438-Q","volume":"283","author":"Pike V. W.","year":"1995","unstructured":"Pike, V. W. and MaCarron, J. A. and Lammerstma, A. A. (1995) First delineation of 5\u2010HT1A receptors in human brain with PET and [11C]WAY 100635. <i>Eur J Pharmacol<\/i>, 283, pp. R1 - 3.","journal-title":"Eur J Pharmacol"},{"key":"E00026","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-8993(95)00104-X","volume":"676","author":"Burnet P. W.","year":"1995","unstructured":"Burnet, P. W. and Eastwood, S. L. and Lacey, K. and Harrison, P. J. (1995) The distribution of 5\u2010HT1A and 5\u2010HT2A receptor mRNA in human brain. <i>Brain Res<\/i>, 676, pp. 157 - 68.","journal-title":"Brain Res"},{"key":"E00027","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0169-328X(92)90104-J","volume":"14","author":"Miquel M. C.","year":"1992","unstructured":"Miquel, M. C. and Doucet, E. and Riad, M. and Adrien, J. and Verge, D. and Hamon, M. (1992) Effect of the selective lesion of serotoninergic neurons on the regional distribution of 5\u2010HT1A receptor mRNA in the rat brain. <i>Brain Res Mol Brain Res<\/i>, 14, pp. 357 - 62.","journal-title":"Brain Res Mol Brain Res"},{"key":"E00028","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","volume":"38","author":"Barnes N. M.","year":"1999","unstructured":"Barnes, N. M. and Sharp, T. (1999) A review of central 5\u2010HT receptors and their function. <i>Neuropharmacology<\/i>, 38, pp. 1083 - 152.","journal-title":"Neuropharmacology"},{"key":"E00029","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1471-4159.1996.66010203.x","volume":"66","author":"Maura G.","year":"1996","unstructured":"Maura, G. and Raiteri, M. (1996) Serotonin 5\u2010HT1D and 5\u2010HT1A receptors respectively mediate inhibition of glutamate release and inhibition of cyclic GMP production in rat cerebellum in vitro. <i>J Neurochem<\/i>, 66, pp. 203 - 09.","journal-title":"J Neurochem"},{"key":"E00030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-2999(88)90345-7","author":"Maura G.","year":"1988","unstructured":"Maura, G. and Roccatagliata, E. and Ulivi, M. and Raiteri, M. (1988) Serotonin\u2010glutamate interaction in rat cerebellun: Involvement of 5\u2010HT1 and 5\u2010HT2 receptors. <i>Eur J Pharmacol<\/i>, pp. 31 - 8.","journal-title":"Eur J Pharmacol"},{"key":"E00031","first-page":"1184","volume":"257","author":"Raiteri M.","year":"1991","unstructured":"Raiteri, M. and Maura, G. and Barzizza, A. (1991) Activation of presynaptic 5\u2010hydroxytryptamine1\u2010like receptors on glutamatergic terminals inhibits N\u2010methyl\u2010D Aspartate\u2010induced cyclic GMP production in rat cerebellar slices. <i>J Pharmacol Exp Ther<\/i>, 257, pp. 1184 - 8.","journal-title":"J Pharmacol Exp Ther"},{"key":"E00032","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(90)90225-U","volume":"175","author":"Darrow E. J.","year":"1990","unstructured":"Darrow, E. J. and Strahlendorf, H. K. and Strahlendorf, J. C. (1990) Response of cerebellar Purkinje cells to serotonin and the 5\u2010HT1A agonists 8\u2010OH\u2010DPAT and ipsapirone in vitro. <i>Eur J Pharmacol<\/i>, 175, pp. 145 - 53.","journal-title":"Eur J Pharmacol"},{"key":"E00033","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1034\/j.1600-0404.2003.02132.x","volume":"107","author":"Monte T. L.","year":"2003","unstructured":"Monte, T. L. and Rieder, C. R. and Tort, A. B. (2003) Use of fluoxetine for treatment of Machado\u2010Joseph disease: an open\u2010label study. <i>Acta Neurol Scand<\/i>, 107, pp. 207 - 10.","journal-title":"Acta Neurol Scand"},{"key":"E00034","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00415-003-1061-9","volume":"250","author":"Bier J. C.","year":"2003","unstructured":"Bier, J. C. and Dethy, S. and Hildebrand, J. and Jacquy, J. and Manto, M. and Martin, J. J. and Seeldrayers, P. (2003) Effects of the oral form of ondansetron on cerebellar dysfunction. A multi\u2010center double\u2010blind study. <i>J Neurol<\/i>, 250, pp. 693 - 7.","journal-title":"J Neurol"},{"key":"E00035","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0006-3223(99)00189-4","volume":"46","author":"Drevets W. C.","year":"1999","unstructured":"Drevets, W. C. and Frank, E. and Price, J. C. and (1999) PET imaging of serotonin 1A receptor binding in depression. <i>Biol Psychiatry<\/i>, 46, pp. 1375 - 87.","journal-title":"Biol Psychiatry"},{"key":"E00036","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archpsyc.57.2.174","volume":"57","author":"Sargent P. A.","year":"2000","unstructured":"Sargent, P. A. and Kjaer, K. H. and Bench, C. J. (2000) Brain serotonin 1A receptor binding measured by positron emission tomography with [11C]WAY\u2010100635: effects of depression and antidepressant treatment. <i>Arch Gen Psychiatry<\/i>, 57, pp. 174 - 80.","journal-title":"Arch Gen Psychiatry"}],"container-title":["The Cerebellum"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1080\/14734220500222318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,17]],"date-time":"2019-03-17T22:04:14Z","timestamp":1552860254000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1080\/14734220500222318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9,5]]}},"alternative-id":["G7N1T44454671624"],"URL":"https:\/\/doi.org\/10.1080\/14734220500222318","relation":{},"ISSN":["1473-4222"],"issn-type":[{"value":"1473-4222","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9,5]]}}}